This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CSE: OILS) (OTCMKTS: OILFF) announced that it was granted its 15th patent from The United States Patent and Trademark Office for the extraction and purification of THC and CBD on June 23. Nextleaf Solutions’s technologies are focused on transforming cannabis or hemp biomass to a standardized cannabinoid oil as efficiently as possible.
This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.
This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. New progressive regulation on cannabis in Colombia.
He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC. with unknown pharmacological and safety profiles.”
In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. Cannabinoid receptors are distributed throughout the body and brain, and I think that also accounts for some of the varied effects of cannabis and the possibility that it can treat many different conditions.
The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S. The Ministry of Health, at our request, has made public the authorization procedure for the manufacture of cannabis extracts on its portal .
DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.
Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?
Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.
Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.
THC and CBD are two popular cannabinoids, and have been used medicinally for centuries. In particular, terpenoids are contained in many herbal plants, and several terpenoids have been shown to be available for pharmaceutical applications. Cannabis possesses healing properties which can aid in a patient’s overall healthcare routine.
In today’s blog, we are joined by Matthew Anderson, Founder/CEO Vanguard Scientific Systems, a world-leading provider of end-to-end solutions for integrated botanical extraction equipment and services. The Cannabinoid Buyer’s Needs of Tomorrow. But is this growth serving the needs of cannabinoid buyers?
The endocannabinoid system consists of cannabinoid receptors all over the body. The compounds THC (tetrahydrocannabinol) and CBD (cannabidiol) found in cannabis signal the same cannabinoid receptors as anandamide. This system enables a connection between body and mind, signaling to all other systems when something feels good or bad.
Nextleaf Solutions Ltd ( CSE:OILS ) (OTCMKTS:OILFF) has been awarded two patents related to extraction of THC and CBD, bringing its total issued patents to ten. READ: Nextleaf Solutions says its distillation plant on pace to be completed by end of this month. ”
– August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL.
(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. These projects will all require pharmaceutical approved API if commercialized. Management Commentary.
There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. Virginia has an “extraction-based” model; it’s not unique. There are some minimum and maximum cannabinoid contents with the program. It’s neither of these things.
Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent. ” ‘Strategic investment’ Jazz Pharmaceuticals currently manufactures the extract, active pharmaceutical ingredients and the formulated drug products at KSP, occupying 12 buildings with more than 400 employees.
(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.
Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts.
Hemp Synergistics, a hemp extraction laboratory producing THC-free custom CBD formulations recently announced it received $1.5 The lab has been designed to resolve the problem of inconsistent THC levels in a range of cannabinoid-based consumer products, the company told Benzinga.
DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%
We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.
Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. Cannabinol – more commonly known as CBN – is one of over one hundred cannabinoids found in the cannabis plant. The CBN cannabinoid begins to form when THC is oxidized. What Is CBN Extraction?
CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It is non-psychoactive and has a multitude of health benefits.
The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.
Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery. This patent focuses on a formulation that includes a cannabinoidextract that is pharmaceutically effective by systemic delivery to the recipient’s oral mucosal lining. InBOLD Inc. announced the issuance of a U.S.
So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Common cannabinoids in cannabis.
Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.
The UNM researchers set out to examine the effectiveness of consuming “legal” hemp oil extracted from the whole Cannabis plant. This allowed the researchers to examine how “full-spectrum” whole plant extracted hemp oil influences brief episodes of pain sensitivity to an affected region. Westlund, Department of Anesthesiology.
NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,
In an interview with Vice, Verra Wellness co-founder Paul Johnson argued that transmucosal delivery of cannabinoids is safer than inhaling cannabis smoke. “I Dissolvable cannabinoids” are having a moment. Ultimately, one could snort any cannabinoid powder or create their own infused powder like canna sugar and ingest it nasally.
If you or a loved one suffer from depression, rare cannabinoid CBC (cannabichromene) may offer hope for a happier future. The third most prevalent cannabinoid in hemp and cannabis, CBC’s mood-elevating properties are about ten times more effective than CBD, making it a promising cannabinoid for reducing stress.
Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.
However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.
Because of the federal legality of these products—and because the Minnesota State Legislature had previously passed a law that made non-food products containing nonintoxicating cannabinoids legal—the CBD industry in Minnesota had taken off in recent years. A theory towards a solution would be for all hemp extracts to be approved by the FDA.
Ethypharm has signed an exclusive license agreement with Clever Leaves for the distribution of medical cannabis extracts in Germany, the most important European market for medical cannabis. Clever Leaves will manufacture and supply EU GMP certified medical cannabis extracts sourced from their facilities in Colombia and Portugal.
An extremely interesting study (Overcoming the Bell-Shaped Dose-Response of Cannabidiol by using Cannabis Extract Enriched in Cannabidiol) was just published out of the Lautenberg Center for General and Tumor Immunology in Jerusalem. Materials Used: Plants, Animals, and Extracts. Cannabis Testing on Mice (AP Photo/Robert F.
A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.
I recently attended two events in Utah headlined by the United Natural Products Alliance (“UNPA”) where its President, Loren Israelsen , discussed the voluminous public comments received by the FDA in response its latest round of questions regarding how over-the-counter cannabis extracts like CBD should be regulated.
The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.
Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”
9,066,920 – “Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy” (“the 920 Patent”). GW Pharma”) and Otsuka Pharmaceuticals Co., Insys Development”) is a pharmaceutical company that focuses on cannabinoids and drug delivery systems. In this case, the subject patent was U.S.
Total Cannabinoids (mgs) 155 620. Full-spectrum extract packed with cannabinoids, terpenes, flavonoids and fatty acids. Chemical-free carbon dioxide extraction for maximum purity and quality. Hemp Extract/CBD that gives you all the benefits nature intended. Feel soothing effects within minutes! Cruelty-free.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content